Barchart.com's Chart of the Day - Crocs
Related Stocks
 CROX - Crocs Inc
SymLastChgPct
CROX16.42+0.25+1.55%

TheChart of the Daybelongs toCrocs(CROX). I found casual footwear stock by using Barchart to sort today's52 Week New Highlist first for the most frequent number of new hihgs in the last month, then again for technical buy signals of 80% or more. Next, I used the Flipcahsrt feature to review the charts of consistent price appreciation. Since the Trend Spotter signaled a buy on 3/19 the stock gained 6.06%.

Crocs, Inc. is a world leader in innovative casual footwear for men, women and children. Crocs offers a broad portfolio of all-season products, while remaining true to its core molded footwear heritage. All Crocs' shoes feature Croslite' material, a proprietary, revolutionary technology that gives each pair of shoes the soft, comfortable, lightweight, non-marking and odor-resistant qualities that Crocs fans have known and love. Crocs celebrates the fun of being a little different and encourages fans to `Find Your Fun` in every colorful pair of shoes.

CROXBarchart's Opinion trading systems are listed below. Please note that the Barchart Opinion indicators are updated live during the session every 10 minutes and can therefore change during the day as the market fluctuates. The indicator numbers shown below therefore may not match what you see live on theBarchart.comweb site when you read this report.

Barchart technical indicators:

  • 96% technical buy signals
  • Trend Spotter buy signal
  • Above its 20, 50 and 100 day moving averages
  • 15 new highs and up 13.26% in the last month
  • Relative Strength Index 70.40%
  • Technical support level at 15.71
  • Recently traded at 15.92 with a 50 day moving average o 13.91

Fundamental factors:

  • Market Cap $1.10 billion
  • Revenue expected to be down .30% this year but grow again by 2.20% next year
  • Earnings estimated to increase 93.80% this year, and another 122.60% next year and continue to compound at an annual rate of 10% a year for the next 5 years
  • Wall Street analysts issued 1 buy and 7 hold recommendations on the stock